Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Carpenter

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Psychiatry|March 17, 2011
Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatmentDiana Martinez, Kenneth M Carpenter, Fei Liu, et al.
Alcoholism, Clinical and Experimental Research|June 13, 2021
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorderJohn J Mariani, Martina Pavlicova, Cale Basaraba, et al.
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experimentAdam C Brooks, Sandra D Comer, Maria A Sullivan, et al.
The American Journal of Psychiatry|January 11, 2017
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus BuprenorphineMaria Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Experimental and Clinical Psychopharmacology|February 26, 2016
Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment responseKenneth M Carpenter, Paul C Amrhein, Krysten W Bold, et al.
Journal of Consulting and Clinical Psychology|April 18, 2012
Training substance abuse clinicians in motivational interviewing using live supervision via teleconferencingJennifer L Smith, Kenneth M Carpenter, Paul C Amrhein, et al.
Experimental and Clinical Psychopharmacology|September 21, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trialKenneth M Carpenter, C Jean Choi, Cale Basaraba, et al.
Drug and Alcohol Dependence|July 19, 2015
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Drug and Alcohol Dependence|November 6, 2020
Quetiapine treatment for cannabis use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Psychiatry|March 17, 2011
Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatmentDiana Martinez, Kenneth M Carpenter, Fei Liu, et al.
Alcoholism, Clinical and Experimental Research|June 13, 2021
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorderJohn J Mariani, Martina Pavlicova, Cale Basaraba, et al.
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experimentAdam C Brooks, Sandra D Comer, Maria A Sullivan, et al.
The American Journal of Psychiatry|January 11, 2017
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus BuprenorphineMaria Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Experimental and Clinical Psychopharmacology|February 26, 2016
Derived relations moderate the association between changes in the strength of commitment language and cocaine treatment responseKenneth M Carpenter, Paul C Amrhein, Krysten W Bold, et al.
Journal of Consulting and Clinical Psychology|April 18, 2012
Training substance abuse clinicians in motivational interviewing using live supervision via teleconferencingJennifer L Smith, Kenneth M Carpenter, Paul C Amrhein, et al.
Experimental and Clinical Psychopharmacology|September 21, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trialKenneth M Carpenter, C Jean Choi, Cale Basaraba, et al.
Drug and Alcohol Dependence|July 19, 2015
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Drug and Alcohol Dependence|November 6, 2020
Quetiapine treatment for cannabis use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Pageof 5